当前位置:首页 - 行情中心 - 山河药辅(300452) - 财务分析 - 现金流量表

山河药辅

(300452)

  

流通市值:25.37亿  总市值:29.94亿
流通股本:1.99亿   总股本:2.34亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金462,598,069.73202,320,789.52852,607,228.14608,654,768.55
  收到的税费返还1,406,834.073,159.9314,003,541.413,223,037.93
  收到其他与经营活动有关的现金2,731,101.241,361,927.3812,670,125.627,927,548.23
  经营活动现金流入小计466,736,005.04203,685,876.83879,280,895.16629,805,354.71
  购买商品、接受劳务支付的现金235,287,699.45120,928,180.95449,467,287.11347,789,700.36
  支付给职工以及为职工支付的现金70,940,874.1537,593,414.65119,631,571.990,286,517.04
  支付的各项税费45,947,849.0119,878,764.7773,573,907.0855,805,560.82
  支付其他与经营活动有关的现金23,551,071.4910,810,957.6144,618,675.332,842,212.04
  经营活动现金流出小计375,727,494.1189,211,317.98687,291,441.39526,723,990.26
  经营活动产生的现金流量净额91,008,510.9414,474,558.85191,989,453.77103,081,364.45
二、投资活动产生的现金流量:
  收回投资收到的现金400,000,000160,000,000635,010,000595,010,000
  取得投资收益收到的现金9,104,798.924,640,910.7813,441,806.611,999,266.95
  处置固定资产、无形资产和其他长期资产收回的现金净额141,726.235,847.3468,719.94438,148.2
  投资活动现金流入小计409,246,525.12164,676,758.08648,920,526.54607,447,415.15
  购建固定资产、无形资产和其他长期资产支付的现金23,434,708.715,785,003.7440,731,731.7430,611,682.35
  投资支付的现金465,000,000200,000,000635,010,000565,010,000
  投资活动现金流出小计488,434,708.7215,785,003.74675,741,731.74595,621,682.35
  投资活动产生的现金流量净额-79,188,183.58-51,108,245.66-26,821,205.211,825,732.8
三、筹资活动产生的现金流量:
  取得借款收到的现金32,000,00012,000,00015,020,00013,020,000
  收到其他与筹资活动有关的现金10,679,337.87-3,461,937.13-
  筹资活动现金流入小计42,679,337.8712,000,00018,481,937.1313,020,000
  偿还债务支付的现金12,000,0002,000,00016,242,60016,142,600
  分配股利、利润或偿付利息支付的现金72,950,890.6812,133.3571,429,876.0771,355,344.45
  筹资活动现金流出小计84,950,890.682,012,133.3587,672,476.0787,497,944.45
  筹资活动产生的现金流量净额-42,271,552.819,987,866.65-69,190,538.94-74,477,944.45
四、汇率变动对现金及现金等价物的影响-2,278,434.82-1,316,352-573,844.6462,271.94
五、现金及现金等价物净增加额-32,729,660.27-27,962,172.1695,403,865.0340,891,424.74
  加:期初现金及现金等价物余额264,915,349.73264,915,349.73169,511,484.7169,511,484.7
  期末现金及现金等价物余额232,185,689.46236,953,177.57264,915,349.73210,402,909.44
补充资料:
  净利润97,095,867.82-173,174,700.26-
  资产减值准备-16.1-58,508.45-
  固定资产和投资性房地产折旧26,260,358.39-51,999,084.41-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧26,260,358.39-51,999,084.41-
  无形资产摊销704,567.52-1,410,192.46-
  长期待摊费用摊销704,435.06-1,013,096.71-
  处置固定资产、无形资产和其他长期资产的损失759,372.2-960,070.63-
  固定资产报废损失1,307.75-144,414.97-
  公允价值变动损失-2,112,295.48--5,918,220.78-
  财务费用10,515,558-14,254,401.55-
  投资损失-9,104,798.92--13,441,806.6-
  递延所得税-368,225.4--6,180,884.16-
  其中:递延所得税资产减少-20,843.77-1,294,600.81-
    递延所得税负债增加-347,381.63--7,475,484.97-
  存货的减少-16,125,842.31--3,558,606.41-
  经营性应收项目的减少-57,175,530.19--53,119,048.94-
  经营性应付项目的增加39,853,752.6-30,913,977.34-
  其他0-279,573.88-
  现金的期末余额232,185,689.46-264,915,349.73-
  减:现金的期初余额264,915,349.73-169,511,484.7-
  现金及现金等价物的净增加额-32,729,660.27-95,403,865.03-
公告日期2026-08-222026-04-232026-04-232025-10-21
审计意见(境内)标准无保留意见
TOP↑